Relmada Therapeutics Inc. (RLMD) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Relmada Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$3.35
+4.36% today
Market cap
$342M
Overall quality
—
Kronos AI 30-day
+52.5%
8 of 8 simulated paths end higher
Relmada Therapeutics Inc. (RLMD) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $342M. It trades at $3.35, up 4.36% today. 2 analysts' average target of $12.00 implies +258.2% from today's price. Kronos AI's 30-day forecast is +52.5% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $12.00 |
| Low – high | $12.00 – $12.00 |
| Analysts | 2 |
| Upside to average | +258.2% |
Kronos AI 30-day forecast
| Expected close | $4.90 (+52.5%) |
| Likely range | +41.9% … +75.7% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.